11th Annual Breast Cancer Awareness Walk, Run, Ride

Translate to Spanish or other 102 languages!

Cancer Awareness Walk, Run, Ride

Mega Doctor News

- Advertisement -

Cancer Awareness Walk, Run, Ride

Date: Oct 06, 2018

Time: 7:30 AM – 1:00 PM

- Advertisement -

Category(s): Community Events * Family Friendly * This event includes:

  • 20, 40 or 60 mile Bicycle Ride, Grand Fondo (100k)
  • 5k Run; Timed Event
  • 2.5k walk
  • Private and Public Business/Service Representatives to help education our community
  • Community Celebration, including food, music, refreshments and activities

During the previous ten years Cancer Survivors, who qualify for financial assistance, have received over $150,000 in support of personal/family living expenses. In addition, over $250,000 has helped our Rio Grande Valley community through financial support of Comfort House Services, Inc., Pink Positive Breast Cancer Foundation, Infinite Love Foundation. For information call 956-454-1168.

Registration: Follow this link.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -